Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancerAAPRO, Matti S; VON MINCKWITZ, Gunter.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 10, pp 3-11, issn 1359-6349, 9 p.Conference Paper

Evidence-based treatment of metastatic breast cancer : 2006 recommendations by the AGO Breast CommissionVON MINCKWITZ, Gunter.European journal of cancer (1990). 2006, Vol 42, Num 17, pp 2897-2908, issn 0959-8049, 12 p.Article

Locoregional Treatment of Primary Breast Cancer: Consensus Recommendations From an International Expert PanelKAUFMANN, Manfred; MORROW, Monica; VON MINCKWITZ, Gunter et al.Cancer. 2010, Vol 116, Num 5, pp 1184-1191, issn 0008-543X, 8 p.Article

Neoadjuvant breast cancer therapy : the German experienceVON MINCKWITZ, Gunter; LOIBL, Sibylle; KAUFMANN, Manfred et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 2, pp 4-9, issn 1359-6349, 6 p.Conference Paper

Use of goserelin in the treatment of breast cancerRODY, Achim; LOIBL, Sibylle; VON MINCKWITZ, Gunter et al.Expert review of anticancer therapy. 2005, Vol 5, Num 4, pp 591-604, issn 1473-7140, 14 p.Article

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapyHOUSSAMI, Nehmat; MACASKILL, Petra; VON MINCKWITZ, Gunter et al.European journal of cancer (1990). 2012, Vol 48, Num 18, pp 3342-3354, issn 0959-8049, 13 p.Article

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and BiologicalUNTCH, Michael; VON MINCKWITZ, Gunter.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 138-141, issn 1052-6773, 4 p.Conference Paper

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patientsEGGEMANN, Holm; IGNATOV, Atanas; SMITH, Bobbie J et al.Breast cancer research and treatment. 2013, Vol 137, Num 2, pp 465-470, issn 0167-6806, 6 p.Article

Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer : Further results from a randomised controlled trialMÜLLER, Christine; CAPUTO, Angelika; SCHUMACHER, Martin et al.European journal of cancer (1990). 2007, Vol 43, Num 11, pp 1654-1661, issn 0959-8049, 8 p.Article

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer : RiTa trialLOIBL, Sibylle; MURMANN, Caroline; SCHWEDLER, Katrin et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 5, pp 953-958, issn 0344-5704, 6 p.Article

Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen : The ARNO 95 studyKAUFMANN, Manfred; JONAT, Walter; HILFRICH, Jörn et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2664-2670, issn 0732-183X, 7 p.Article

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapyAAPRO, Matti; SCHWENKGLENKS, Matthias; LYMAN, Gary H et al.Critical reviews in oncology/hematology. 2010, Vol 74, Num 3, pp 203-210, issn 1040-8428, 8 p.Article

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cellsSPÄNKUCH-SCHMITT, Birgit; WOLF, Georg; SOLBACH, Christine et al.Oncogene (Basingstoke). 2002, Vol 21, Num 20, pp 3162-3171, issn 0950-9232Article

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)VON MINCKWITZ, Gunter; DARB-ESFAHANI, Silvia; CLEMENS, Michael R et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 863-870, issn 0167-6806, 8 p.Article

Effect of Luteinizing Hormone-Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO StudyGERBER, Bernd; VON MINCKWITZ, Gunter; FEHM, Tanja et al.Journal of clinical oncology. 2011, Vol 29, Num 17, pp 2334-2341, issn 0732-183X, 8 p.Article

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) - The German Adjuvant Breast Cancer GroupEIERMANN, Wolfgang; GRAF, Erika; KAUFMANN, Manfred et al.European journal of cancer (1990). 2010, Vol 46, Num 1, pp 84-94, issn 0959-8049, 11 p.Article

The role of early expression of inducible nitric oxide synthase in human breast cancerLOIBL, Sibylle; BUCK, Angela; STRANK, Cornelia et al.European journal of cancer (1990). 2005, Vol 41, Num 2, pp 265-271, issn 0959-8049, 7 p.Article

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus ConferenceTOI, Masakazu; BENSON, John R; PEGRAM, Mark D et al.Breast cancer research and treatment. 2012, Vol 136, Num 3, pp 919-926, issn 0167-6806, 8 p.Article

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugsFASCHING, Peter A; VON MINCKWITZ, Gunter; BECKMANN, Matthias W et al.Breast cancer research and treatment. 2007, Vol 101, Num 1, pp 95-104, issn 0167-6806, 10 p.Article

Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer : A randomized trial (GABG-IV D-93)-The German adjuvant breast cancer groupKAUFMANN, Manfred; GRAF, Erika; SCHUMACHER, Martin et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7842-7848, issn 0732-183X, 7 p.Article

HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancerKONECNY, Gottfried E; THOMSSEN, Christoph; MÖBUS, Volker et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 15, pp 1141-1151, issn 0027-8874, 11 p.Article

International expert panel on the use of Primary (preoperative) systemic treatment of operable breast cancer: Review and recommendationsKAUFMANN, Manfred; VON MINCKWITZ, Gunter; BLOHMER, Jens-Uwe et al.Journal of clinical oncology. 2003, Vol 21, Num 13, pp 2600-2608, issn 0732-183X, 9 p.Article

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisCORTAZAR, Patricia; LIJUN ZHANG; SWAIN, Sandra M et al.Lancet (British edition). 2014, Vol 384, Num 9938, pp 164-172, issn 0140-6736, 9 p.Article

Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyMAASS, Nicolai; HARBECK, Nadia; WAGNER, Steffen et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 12, pp 2047-2056, issn 0171-5216, 10 p.Article

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast CancerVON MINCKWITZ, Gunter; SCHMITT, Wolfgang D; HILFRICH, Jörn et al.Clinical cancer research (Print). 2013, Vol 19, Num 16, pp 4521-4531, issn 1078-0432, 11 p.Article